SCHEMBL7676191

SCHEMBL7676191

C[C@H](NCc1ccccc1)c1ccc(Cl)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.60
ATM Q13315 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C19 P33261 1/20 0.56
AKT1 P31749 2/20 0.54
TDP1 Q9NUW8 1/20 0.54
CASR P41180 2/20 0.53
HTR1A P08908 3/20 0.52
HTR7 P34969 2/20 0.52
HTR6 P50406 2/20 0.52
POLB P06746 2/20 0.51
SIGMAR1 Q99720 1/20 0.50
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
MAPK1 P28482 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
GABRB1 P18505 1/20 0.46
GABRB2 P47870 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5268968 0.93 SMN1; SMN2 (0.70) SMN1; SMN2ATML3MBTL1CYP1A2CYP2D6
SCHEMBL2168415 0.93 SMN1; SMN2 (0.70) SMN1; SMN2ATML3MBTL1CYP1A2CYP2D6
SCHEMBL11881252 0.91 SMN1; SMN2 (0.70) SMN1; SMN2CYP1A2CYP2D6CYP2C19CASR
SCHEMBL29560 0.87 SMN1; SMN2 (0.76) SMN1; SMN2CYP1A2CYP2D6CYP2C19CASR
SCHEMBL774613 0.87 SMN1; SMN2 (0.76) SMN1; SMN2CYP1A2CYP2D6CYP2C19CASR
SCHEMBL79765 0.87 SMN1; SMN2 (0.76) SMN1; SMN2CYP1A2CYP2D6CYP2C19CASR
SCHEMBL5274105 0.86 MEN1 (0.67) SMN1; SMN2TDP1POLBMEN1KMT2A
Hydrochloric Acid SCHEMBL5493749 0.85 SMN1; SMN2 (0.79) SMN1; SMN2CYP1A2CYP2D6CYP2C19TDP1
SCHEMBL27939948 0.85 SMN1; SMN2 (0.73) SMN1; SMN2CYP1A2CYP2D6CYP2C19CASR
Hydrochloric Acid SCHEMBL9635019 0.85 SMN1; SMN2 (0.79) SMN1; SMN2CYP1A2CYP2D6CYP2C19TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6500986-B1 RACEMIZATION OF OPTICALLY ACTIVE AMIDES; CONVERSION TO AMINES BAYER AKTIENGESELLSCHAFT (DE) 2002-12-31 US claimed
EP-0757981-B1 Process for the preparation of racemic amino derivatives BAYER AG (DE) 2000-02-16 EP claimed